Goldman Sachs Downgrades U.S. Large Cap Biotech Shares To Neutral
More News related to BBH
- Barclays Gets Bullish On US Biotechnology Sector (BBH)
- Goldman Sachs Downgrades U.S. Large Cap Biotech Shares To Neutral
- ETF Movers: Biotech ETFs On the Moves Following ImClone Offer
- ETF Movers 7/28: Financial Select Sector (XLF) Lower, Biotech HOLDRs (BBH) Higher, More...
- ETF Movers 7/22: Semiconductor HOLDRs (SMH) Slammed, KBW Regional Banking (KRE) Weak
More News related to Downgrades
- Unusual 11 Mid-Day Movers 11/23: ABIO, SEED, FNET, CDTI Higher; NYNY, GGR, TTIL, PEET Lower
- Best of the Web 11/23: Suicides On the Rise, U.S. Debt Service Could Top $700B, Really? An Insider Trading Beauty Queen
- Notable Analyst Rating Changes 11/23: SBUX, DE, SEED, NDAQ Upgraded; AGU, TRA, CIEN, FL Downgraded
- Notable Mergers and Acquisitions of the Day 11/23: GMCR/DDRX, PBCT/FIF, CIEN, BDX, IDTI
- Morning Movers 11/23: ABIO, SEED, FIF, FNET, DDRX, JOBS Higher; BBI, CGA, BOFL, CEPH Lower
Goldman Sachs Downgrades U.S. Large Cap Biotech Shares To Neutral.
Related ETF: Biotech HOLDRs (NYSE: BBH).
Related Categories
DowngradesStocks Mentioned
+0.55Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
